Northeast Investment Management Abbott Laboratories Transaction History

Northeast Investment Management

$2.19 Billion
Q4 2024

A detailed history of Northeast Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Northeast Investment Management holds 93,661 shares of ABT stock, worth $12.3 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

93,661

Previous 93,780 0.13%

Holding current value

$12.3 Million

Previous $10.7 Million 0.92%

% of portfolio

0.48%

Previous 0.49%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$111.93 - $119.39 $13,319 - $14,207	-119 Reduced 0.13%	93,661 $10.6 Million
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $316,221 - $373,290	-3,160 Reduced 3.26%	93,780 $10.7 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $139,712 - $155,954	-1,387 Reduced 1.41%	96,940 $10.1 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $163,622 - $180,714	-1,494 Reduced 1.5%	98,327 $11.2 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $381,323 - $466,771	-4,228 Reduced 4.06%	99,821 $11 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $333,972 - $400,711	-3,496 Reduced 3.25%	104,049 $10.1 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $848,366 - $945,257	-8,418 Reduced 7.26%	107,545 $11.7 Million
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $492,145 - $579,284	-5,081 Reduced 4.2%	115,963 $11.7 Million
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $284,894 - $334,225	-2,997 Reduced 2.42%	121,044 $13.3 Million
Q3 2022 Oct 28, 2022	SELL	$96.76 - $112.03 $436,097 - $504,919	-4,507 Reduced 3.51%	124,041 $12 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $284,877 - $344,325	-2,791 Reduced 2.13%	128,548 $14 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $63,737 - $77,723	-559 Reduced 0.42%	131,339 $15.5 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $61,115 - $74,832	-529 Reduced 0.4%	131,898 $18.6 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $417,759 - $462,163	-3,581 Reduced 2.63%	132,427 $15.6 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $1.29 Million - $1.51 Million	-12,157 Reduced 8.21%	136,008 $15.8 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $460,393 - $542,412	-4,230 Reduced 2.78%	148,165 $17.8 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $57,645 - $62,816	-549 Reduced 0.36%	152,395 $16.7 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $284,633 - $345,666	3,106 Added 2.07%	152,944 $16.6 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $2.74 Million - $3.51 Million	35,813 Added 31.41%	149,838 $13.7 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $102,019 - $149,180	-1,624 Reduced 1.4%	114,025 $9 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $425,131 - $473,271	-5,415 Reduced 4.47%	115,649 $10 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $198,707 - $215,460	-2,428 Reduced 1.97%	121,064 $10.1 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $238,609 - $278,290	3,274 Added 2.72%	123,492 $10.4 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $232,961 - $281,651	-3,518 Reduced 2.84%	120,218 $9.61 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $398,277 - $451,190	-6,075 Reduced 4.68%	123,736 $8.95 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $209,429 - $252,651	-3,444 Reduced 2.58%	129,811 $9.52 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $115,830 - $127,842	-2,012 Reduced 1.49%	133,255 $8.13 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $41,470 - $46,887	737 Added 0.55%	135,267 $8.11 Million
Q4 2017 Jan 29, 2018	SELL	$53.68 - $57.47 $86,263 - $92,354	-1,607 Reduced 1.18%	134,530 $7.68 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $6.54 Million - $7.3 Million	136,137	136,137 $7.26 Million

Others Institutions Holding ABT

# of Institutions

3,377

Shares Held

1.33B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Account

Northeast Investment Management Abbott Laboratories Transaction History